The phase III trial in the era of targeted therapy: unraveling the "go or no go" decision, J Clin Oncol, vol.21, pp.3683-95, 2003. ,
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov, JAMA Intern Med, vol.173, pp.972-981, 2013. ,
Do molecularly targeted agents in oncology have reduced attrition rates?, Nat Rev Drug Discov, vol.8, pp.15-21, 2009. ,
Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens, J Clin Oncol, vol.23, pp.6982-91, 2005. ,
The design of phase II clinical trials testing cancer therapeutics: consensus recommendations from the clinical trial design task force of the national cancer institute investigational drug steering committee, Clin Cancer Res, vol.16, pp.1764-1773, 2010. ,
Quality of reporting of phase II trials: a focus on highly ranked oncology journals, Ann Oncol, vol.25, pp.536-577, 2014. ,
Modernizing Eligibility Criteria for Molecularly Driven Trials, J Clin Oncol, vol.33, pp.2815-2835, 2015. ,
Sufficient life expectancy": an amazing inclusion criterion in cancer phase II-III trials, J Clin Oncol, vol.27, p.105, 2009. ,
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy, Br J Cancer, vol.92, pp.1001-1006, 2005. ,
Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform, vol.42, pp.377-81, 2009. ,
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience, Br J Cancer, vol.98, pp.1029-1062, 2008. ,
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?, BMC Cancer, vol.11, p.426, 2011. ,
Impact of precision medicine in diverse cancers: a meta-analysis of phase II clinical trials, J Clin Oncol, vol.33, pp.3817-3842, 2015. ,
A goodness-of-fit test for the multiple logistic regression model, Commun Stat, vol.10, pp.1043-69, 1980. ,
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials, Ann Oncol, vol.11, pp.151-157, 2000. ,
Developing an objective marker to optimize patient selection and predict survival benefit in early-phase cancer trials, Cancer, vol.120, pp.262-70, 2014. ,
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients, Eur J Cancer, vol.40, pp.2293-306, 2004. ,
Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review, Cancer, vol.91, pp.2214-2235, 2001. ,
Direct regulation of TWIST by HIF-1 alpha promotes metastasis, Nat Cell Biol, vol.10, pp.295-305, 2008. ,
Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China, Tumour Biol, vol.31, pp.633-674, 2010. ,
The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy, Dis Colon Rectum, vol.56, pp.1036-1078, 2013. ,
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group, J Clin Oncol, vol.14, pp.2901-2908, 1996. ,
Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma, Cancer, vol.92, pp.2399-405, 2001. ,
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients, Ann Oncol, vol.13, pp.308-325, 2002. ,
Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer? Lung Cancer, vol.66, pp.8-14, 2009. ,
The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study, Gynecol Oncol, vol.132, pp.551-556, 2014. ,
Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma, Int J Gynecol Cancer, vol.23, pp.312-319, 2013. ,
Prognostic value of hypercalcaemia and leucocytosis in resected oral squamous cell carcinoma, Br J Oral Maxillofac Surg, vol.52, pp.425-456, 2014. ,
Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients, Cancer, vol.115, pp.3919-3942, 2009. ,
Why does my patient have leukocytosis?, Hematol Oncol Clin North Am, vol.26, pp.303-322, 2012. ,